Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Finnegan

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Neurobehavioral Toxicology and Teratology|July 1, 1984
Developmental outcome of children born to methadone maintained women: a review of longitudinal studiesK Kaltenbach, L P Finnegan
Neurobehavioral Toxicology and Teratology|July 1, 1986
Neonatal abstinence syndrome, pharmacotherapy and developmental outcomeK Kaltenbach, L P Finnegan
British Heart Journal|November 1, 1973
Isolated tricuspid stenosisP Finnegan, L D Abrams
NIDA Research Monograph|January 1, 1992
Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment programK A Kaltenbach, L P Finnegan
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Attitudes to health care: student research in a downtown coreA P Finnegan, E J Monkman
Journal of Perioperative Practice|October 31, 2018
Nurse education in the British armed forcesMajor Chris Carter, Alan P Finnegan
Frontiers in Pediatrics|January 8, 2024
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do notJohn J McCarthy, Loretta P Finnegan
Irish Medical Journal|April 29, 2024
Skin reactions associated with glucose monitoring devicesP Finnegan, E Porter, J Bourke
Journal of Women'S Health|June 1, 1997
Observations from the CDC. The Prevention Research Centers Program: collaboration in women's healthP L Riley, L P Finnegan
American Journal of Obstetrics & Gynecology MFM|January 16, 2021
Methadone dose at delivery is not an accurate proxy for fetal exposureJohn J McCarthy, Loretta P Finnegan
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Neurobehavioral Toxicology and Teratology|July 1, 1984
Developmental outcome of children born to methadone maintained women: a review of longitudinal studiesK Kaltenbach, L P Finnegan
Neurobehavioral Toxicology and Teratology|July 1, 1986
Neonatal abstinence syndrome, pharmacotherapy and developmental outcomeK Kaltenbach, L P Finnegan
British Heart Journal|November 1, 1973
Isolated tricuspid stenosisP Finnegan, L D Abrams
NIDA Research Monograph|January 1, 1992
Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment programK A Kaltenbach, L P Finnegan
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Attitudes to health care: student research in a downtown coreA P Finnegan, E J Monkman
Journal of Perioperative Practice|October 31, 2018
Nurse education in the British armed forcesMajor Chris Carter, Alan P Finnegan
Frontiers in Pediatrics|January 8, 2024
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do notJohn J McCarthy, Loretta P Finnegan
Irish Medical Journal|April 29, 2024
Skin reactions associated with glucose monitoring devicesP Finnegan, E Porter, J Bourke
Journal of Women'S Health|June 1, 1997
Observations from the CDC. The Prevention Research Centers Program: collaboration in women's healthP L Riley, L P Finnegan
American Journal of Obstetrics & Gynecology MFM|January 16, 2021
Methadone dose at delivery is not an accurate proxy for fetal exposureJohn J McCarthy, Loretta P Finnegan
Pageof 18